A1ATU

Torasemide

Created:2024-05-31
Last modified:  2025-11-11

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count44
Chiral Atom Count0
Bond Count45
Aromatic Bond Count12
2D diagram of A1ATU
Toggle HydrogenToggle Labels

Chemical Component Summary

NameTorasemide
Systematic Name (OpenEye OEToolkits)1-[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl-3-propan-2-yl-urea
FormulaC16 H20 N4 O3 S
Molecular Weight348.42
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01O=S(=O)(NC(=O)NC(C)C)c1cnccc1Nc1cc(C)ccc1
SMILESCACTVS3.385CC(C)NC(=O)N[S](=O)(=O)c1cnccc1Nc2cccc(C)c2
SMILESOpenEye OEToolkits2.0.7Cc1cccc(c1)Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C
Canonical SMILESCACTVS3.385 CC(C)NC(=O)N[S](=O)(=O)c1cnccc1Nc2cccc(C)c2
Canonical SMILESOpenEye OEToolkits2.0.7 Cc1cccc(c1)Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C
InChIInChI1.06 InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)
InChIKeyInChI1.06 NGBFQHCMQULJNZ-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB00214 
NameTorasemide
Groups
  • investigational
  • approved
DescriptionTorasemide is a high-ceiling loop diuretic.[A174463] Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent.[A319] Torasemide was first approved for clinical use by the FDA in 1993.[L5257]
Synonyms
  • 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea
  • Torsemide
  • Torasémide
  • Torasemide
  • Torasemidum
Brand Names
  • Demadex Tablets - 10mg
  • Demadex Tablets - 100mg
  • Soaanz
  • Demadex Injection - 10mg/ml
  • Demadex
IndicationTorasemide is indicated for the treatment of edema associated with congestive heart failure, renal or hepatic diseases. From this condition, it has been observed that torasemide is very effective in cases of kidney failure.[FDA label] As well, torasemide is approved to be used as an antihypertensive agent either alone or in combination with other antihypertensives.[FDA label]
Categories
  • Antihypertensive Agents
  • Antihypertensive Agents Indicated for Hypertension
  • Cardiovascular Agents
  • Cytochrome P-450 CYP2C8 Substrates
  • Cytochrome P-450 CYP2C9 Inhibitors
ATC-Code
  • C03CA04
  • G01AE10
CAS number56211-40-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Solute carrier family 12 member 2MEPRPTAPSSGAPGLAGVGETPSAAALAAARVELPGTAVPSVPEDAAPAS...unknowninhibitor
Solute carrier family 12 member 1MSLNNSSNVFLDSVPSNTNRFQVSVINENHESSAAADDNTDPPHYEETSF...unknowninhibitor
Cytochrome P450 2C8MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...unknownsubstrate
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknownsubstrate,inhibitor
AlbuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1148
PubChem 51371498, 41781
ChEMBL CHEMBL1148
ChEBI CHEBI:9637
CCDC/CSD TORSEM05, TORSEM02, TORSEM, TORSEM01